ATHE Alterity Therapeutics Ltd Total Business Assets
Alterity Therapeutics focuses on developing treatments for rare brain pathologies, mitigating risks through a broad portfolio of molecules. The strategy relies on partnerships with leading scientific centers dedicated to combating neuronal degeneration. Current R&D status and the absence of sales are driving cost increases, which is reflected in the market value dynamics of the asset on GURU.Markets, where total assets amount to 31.03.
Analytical breakdowns and data insights for company alteritytherapeutics.com (ATHE)
- stock value and consensus price forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Alterity Therapeutics|ATHE - Long-Term Debt to Equity|Current Liabilities to Capital Alterity Therapeutics Limited|ATHE - Company Aggregate Debts|Debts to Book Capitalization Alterity Therapeutics Limited|ATHE - Company Long-Term Debt|Company Short-Term Debt Alterity Therapeutics|Intermediate Liquidity Ratio alteritytherapeutics.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Alterity Therapeutics
Total assets reflect the aggregate value of the company's resources, calculated reverse-engineered via return on assets (ROA) to eliminate reporting time lags. Analyzing the aggregate resources of Alterity Therapeutics (ATHE) allows for an assessment of its financial stability, which is critical given the high dependence on external contract laboratories and the difficulty of switching vendors due to stringent regulatory restrictions.
Main competitors
Company Assets biogen.com (BIIB)|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|BHVN (Biohaven Ltd.) - Company Total Assets|Company Total Assets amylyx.com|Aggregate Company Assets Trevi Therapeutics, Inc. (TRVI)|Aggregate Company Assets PRAX (Praxis Precision Medicines Inc)|Anavex Corp - Cumulative Company Assets|Aggregate Business Assets CBLL (CeriBell EEG)|Prothena Corporation plc - Company Total Assets|Company Assets Alector, Inc.|Annexon (ANNX) - Aggregate Company Assets|Omeros - Aggregate Asset Value|NGNE (Neurogene Corp) - Company Total Assets|AC Immune Inc (ACIU) - Company Total Asset Base|Cumulative Company Assets VYGR (Voyager Therapeutics)|Aggregate Business Assets NMRA|Scilex - Cumulative Company Assets|Tevogen Bio Holdings Inc. (TVGN) - Company Assets|ACOG: Cumulative Company Assets|Aggregate Asset Value CGTX (Cognition Therapeutics Inc.)|IKT (Inhibikase Therapeutics) - Cumulative Company Assets|SAVA: Aggregate Business Assets|ASRT (Assertio Holdings) - Company Total Assets|COYA: Aggregate Asset Value|Company Total Assets VTGN|OVID - Company Assets|Aggregate Company Assets Acumen Pharmaceuticals ABOS|Aggregate Asset Value CRVO|Clene Nanomedicine - Company Total Assets|PEPG - Company Total Assets|Jupiter Neurosciences (JUNS) - Aggregate Company Assets|Total Asset Value of Company RLMD (Relmada Corp)|ANVS (Annovis Bio, Inc.) - Company Total Assets|Company Assets Grace Tx GRCE|Cumulative Company Assets AIFF (Firefly Neuroscience)|Company Total Assets anewmeds.com (KLTO)|NeuroSense Therapeutics Ltd. - Cumulative Company Assets|Aggregate Business Assets RVPH (Reviva Pharmaceuticals, Inc.)|MetaVia, Inc. - Company Total Assets|Company Total Asset Base neuraxis.com NRXS|HSDT: Company Total Assets|Cumulative Company Assets Passage Bio|Aggregate Company Assets Neuphoria Therapeutics, Inc.|Minerva (NERV) - Company Total Asset Base|Company Total Assets ATHA|Company Total Assets addextherapeutics.com (ADXN)|Alzamend Neuro - Cumulative Company Assets|Aggregate Business Assets CYCN (Cyclerion Therapeutics Inc.)|Protagenic - Company Total Assets|Aggregate Asset Value KTTA (Pasithea Therapeutics)|CRGT: Company Total Assets|Company Assets avenuetx.com (ATXI)|Aggregate Company Assets BrainStorm Cell Therapeutics|Total Business Assets CARA (Cara Therapeutics Inc.)|Company Total Assets CHRO|ELYM - Company Assets|Intra-Cellular Therapies, Inc. - Cumulative Company Assets|Company Total Assets longboardpharma.com LBPH|MRNS - Aggregate Company Assets|Aggregate Asset Value NKGN (NKGen Biotech Inc)|NeuroBo (NRBO) - Aggregate Company Assets|Company Assets Sage Therapeutics Inc (SAGE)|SNPX (Synaptogenix, Inc.) - Company Total Assets|Company Total Assets trevena.com|Aggregate Company Assets Vigil Neuroscience (VIGL)|Aggregate Company Assets WENA (anewmeds.com)|Cerevel - Cumulative Company Assets